| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute ischemic stroke revealing late-onset glycogen storage disease
|
Aissi, M.
|
|
2017
|
173 |
1-2 |
p. 75-77
3 p.
|
article
|
| 2 |
Address from the previous President, January 2017
|
Delattre, J.-Y.
|
|
2017
|
173 |
1-2 |
p. 2-3
2 p.
|
article
|
| 3 |
Adress from the President, January 2017
|
Edan, G.
|
|
2017
|
173 |
1-2 |
p. 4-5
2 p.
|
article
|
| 4 |
Can we discontinue disease-modifying treatments in multiple sclerosis patients? Comments
|
Gouider, R.
|
|
2017
|
173 |
1-2 |
p. 44-46
3 p.
|
article
|
| 5 |
Can we discontinue disease-modifying treatments in multiple sclerosis patients? No
|
Papeix, C.
|
|
2017
|
173 |
1-2 |
p. 41-43
3 p.
|
article
|
| 6 |
Can we discontinue disease-modifying treatments in multiple sclerosis patients? Yes
|
Laplaud, David
|
|
2017
|
173 |
1-2 |
p. 38-40
3 p.
|
article
|
| 7 |
Capnocytophaga canimorsus, a rare cause of bacterial meningitis
|
Beltramone, M.
|
|
2017
|
173 |
1-2 |
p. 74-75
2 p.
|
article
|
| 8 |
“De-novo” consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes
|
Ruggeri, J.
|
|
2017
|
173 |
1-2 |
p. 55-61
7 p.
|
article
|
| 9 |
Editorial
|
Azulay, J.-P.
|
|
2017
|
173 |
1-2 |
p. 1-
1 p.
|
article
|
| 10 |
Editorial
|
Dauvilliers, Y.
|
|
2017
|
173 |
1-2 |
p. 6-7
2 p.
|
article
|
| 11 |
Editorial Board
|
|
|
2017
|
173 |
1-2 |
p. i-
1 p.
|
article
|
| 12 |
Erratum to “Brain connectivity and auditory hallucinations: In search of novel noninvasive brain stimulation therapeutic approaches for schizophrenia” [Rev. Neurol. 159 (11) (2016)]
|
Thomas, F.
|
|
2017
|
173 |
1-2 |
p. 79-
1 p.
|
article
|
| 13 |
French consensus. Hypersomnolence: Evaluation and diagnosis
|
Dauvilliers, Y.
|
|
2017
|
173 |
1-2 |
p. 19-24
6 p.
|
article
|
| 14 |
French consensus. Idiopathic hypersomnia: Investigations and follow-up
|
Leu-Semenescu, S.
|
|
2017
|
173 |
1-2 |
p. 32-37
6 p.
|
article
|
| 15 |
French consensus. Management of patients with hypersomnia: Which strategy?
|
Lopez, R.
|
|
2017
|
173 |
1-2 |
p. 8-18
11 p.
|
article
|
| 16 |
French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up
|
Monaca, C.
|
|
2017
|
173 |
1-2 |
p. 25-31
7 p.
|
article
|
| 17 |
Liste des membres (2016)
|
|
|
2017
|
173 |
1-2 |
p. 80-100
21 p.
|
article
|
| 18 |
Newer anti-epileptic drugs, vitamin status and neuropathy: A cross-sectional analysis
|
Cahill, V.
|
|
2017
|
173 |
1-2 |
p. 62-66
5 p.
|
article
|
| 19 |
Postinfectious longitudinal extensive myelopathy after hand-foot-and-mouth disease in an immunocompetent adult
|
Baldé, A.O.M.
|
|
2017
|
173 |
1-2 |
p. 77-78
2 p.
|
article
|
| 20 |
Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening
|
Sablot, D.
|
|
2017
|
173 |
1-2 |
p. 47-54
8 p.
|
article
|
| 21 |
SMART syndrome: Classic transient symptoms leading to an unusual unfavorable outcome
|
Bompaire, F.
|
|
2017
|
173 |
1-2 |
p. 67-73
7 p.
|
article
|
Journal description